Clinical trial
A Long-Term Safety Study of ALKS 5461
NCT02141399
Study timeline
Study start (actual)2014-05-01Date precision: month
Registry last updated2018-12-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Interventions
ALKS 5461DRUG
Sponsors & collaborators
Alkermes, Inc.lead sponsor
Mapped research locations
New YorkNew York, United States5BerlinGermany3BudapestHungary3SofiaBulgaria3HoustonTexas, United States2ChicagoIllinois, United States2PhiladelphiaPennsylvania, United States2DallasTexas, United States2BaltimoreMaryland, United States2St LouisMissouri, United States2BirminghamAlabama, United States2CincinnatiOhio, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02141399 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.